Normal view MARC view ISBD view

Cardiac Resynchronization Therapy in Older Adults with Heart Failure. [Review]

MedStar author(s):

Citation: Heart Failure Clinics. 13(3):581-587, 2017 JulPMID: 28602373Institution: MedStar Heart & Vascular InstituteForm of publication: Journal ArticleMedline article type(s): Journal Article | ReviewSubject headings: *Cardiac Resynchronization Therapy/mt [Methods] | *Heart Failure/th [Therapy] | Age Factors | Aged | Humans | Middle AgedYear: 2017 ISSN:

1551-7136

Name of journal: Heart failure clinicsAbstract: Copyright (c) 2017 Elsevier Inc. All rights reserved.Heart failure is a disease of poor prognosis marked by frequent hospitalizations, premature death, and impaired quality of life. Despite advances in medical therapy for patients with heart failure and reduced ejection fraction, mortality and hospitalizations with advanced disease are still increased and the quality of life continues to be poor in this population. The advent of cardiac resynchronization therapy has led to a significant improvement in both survival and symptom management in patients with heart failure and reduced ejection fraction. Its beneficial effects in the elderly population, however, are not well-defined.All authors: Ahmed A, Lam PH, Singh S, Taffet GEFiscal year: FY2017Digital Object Identifier:

https://dx.doi.org/10.1016/j.hfc.2017.02.011

Date added to catalog: 2017-06-16

Holdings ( 1 )
Title notes ( 3 )

Holdings
Item type	Current library	Collection	Call number	Status	Date due	Barcode
Journal Article	MedStar Authors Catalog	Article	28602373	Available		28602373

Heart failure is a disease of poor prognosis marked by frequent hospitalizations, premature death, and impaired quality of life. Despite advances in medical therapy for patients with heart failure and reduced ejection fraction, mortality and hospitalizations with advanced disease are still increased and the quality of life continues to be poor in this population. The advent of cardiac resynchronization therapy has led to a significant improvement in both survival and symptom management in patients with heart failure and reduced ejection fraction. Its beneficial effects in the elderly population, however, are not well-defined.

English